Analysing the Top 15 Healthtech Companies Shaping the Future
Published 27 October 2026 · 15 companies · AI-generated copy
The Healthtech sector continues its dynamic growth, with innovative companies securing crucial early-stage investment to develop groundbreaking solutions. This analysis delves into a curated dataset of 15 Healthtech companies, all having successfully completed their Seed funding rounds.
Cumulatively, these companies have raised a substantial $85,200,000, underscoring the strong investor confidence in health technology advancements. We examine where this capital is being deployed, the geographical hotspots, and the technological areas attracting the most attention.
Total Funding (USD)
$85.2m
Average
$5.7m
Median
$4.2m
Top-10 share
89.8%
The Biggest Raises
A total of $85,200,000 has been secured across these 15 Healthtech companies at Seed stage, with an average funding of $5,680,000. CardioSense leads the pack, having raised $15,400,000, creating a significant $3,300,000 gap between it and the second-highest funded company. The top 10 companies collectively account for a substantial 89.8% of the total funding.
Where They're Based
London emerges as a dominant hub, hosting 5 companies that have collectively secured $39.4m, representing 46.2% of the total funding. Oxford also proves significant with 2 companies raising $14.3m, accounting for 16.8% of the total, whilst Cambridge contributed $12.1m from 1 company (14.2%). Other notable locations include Edinburgh with $6.3m (7.4%) and Manchester with $3.8m (4.5%).
What They're Building
Innovations in Oncology are prominently featured, with 3 companies focusing on this critical area, whilst AI diagnostics and Wearables each represent 2 companies amongst the top sector tags. Mental health solutions and broader AI applications also demonstrate their importance, with 2 companies each developing advancements in these fields. Medical imaging, Radiology, and Remote patient monitoring are also key areas of development.
Trends to Watch
The strong presence of AI across diagnostics, natural language processing, and robotic assistance points towards a future where intelligent systems optimise healthcare delivery. Wearable technology combined with remote patient monitoring capabilities suggests a growing emphasis on proactive and continuous health management outside traditional clinical settings. Furthermore, targeted solutions for complex diseases like cancer, through oncology and biomarker detection, indicate a focus on precision health and early intervention.
Key Insights
- ▸London is a significant hub, attracting 46.2% of the total funding across 5 companies.
- ▸CardioSense leads the funding race with $15,400,000, creating a substantial lead.
- ▸The top 10 companies command 89.8% of the total $85,200,000 funding.
- ▸The median funding for a Healthtech company in this dataset stands at $4,200,000.
- ▸AI-driven solutions and wearables are prominent themes amongst the innovations.
- ▸Oncology is a key focus, attracting investment in three distinct companies.
Funding (USD) by Region
Top Sector Tags
Full Rankings (15 of 15)
| MediScan AI | $4200000 | London | Medical imaging; AI diagnostics; Radiology | MediScan AI develops deep-learning software for automated analysis of radiology images to help radiologists prioritise urgent cases. |
| CareLoop | $3800000 | Manchester | Remote patient monitoring; Chronic disease management; Wearables | CareLoop builds wearable-integrated software for continuous patient monitoring and early deterioration alerts. |
| GenomixPro | $12100000 | Cambridge | Genomics; Drug discovery; Bioinformatics; Oncology | GenomixPro develops a cloud platform for genomic data analysis and drug target identification aimed at accelerating rare-disease research. |
| TherapyOS | $1900000 | Bristol | Mental health; Digital therapeutics; Cognitive behavioural therapy | TherapyOS offers a CBT-based mobile app for anxiety and depression management that is clinically validated and NICE-compliant. |
| NanoMed | $8700000 | Oxford | Drug delivery; Nanotechnology; Oncology; Targeted therapy | NanoMed develops targeted nanoparticle drug delivery systems for solid tumour treatment to reduce off-target toxicity. |
| HealthChain | $2500000 | London | Healthcare data; Blockchain; Patient records; Interoperability | HealthChain builds a blockchain-based platform for secure consent-driven patient data sharing between NHS trusts. |
| SurgAssist | $6300000 | Edinburgh | Surgical robotics; AI; Orthopaedics; Computer vision | SurgAssist develops AI-guided robotic assistance tools for orthopaedic surgeons to improve implant placement accuracy. |
| PharmaTrack | $1200000 | Leeds | Pharmaceutical supply chain; Drug traceability; Compliance | PharmaTrack builds a serialisation and traceability platform for pharmaceutical logistics to meet EU Falsified Medicines Directive requirements. |
| BioMark | $9500000 | London | Biomarkers; Diagnostics; Early detection; Oncology | BioMark develops blood-based biomarker tests for early cancer and neurological disease detection from a standard blood draw. |
| VisionRx | $3100000 | Glasgow | Ophthalmology; AI diagnostics; Telehealth; Screening | VisionRx builds AI-powered remote eye examination tools to bring specialist-level screening to underserved rural communities. |
| WellnessAI | $2200000 | Birmingham | Preventive health; Personalisation; Nutrition; Behaviour change | WellnessAI develops a personalised health coaching app using AI and biomarker data to nudge healthier lifestyle choices. |
| CardioSense | $15400000 | London | Cardiology; Wearables; Remote monitoring; ECG; Arrhythmia | CardioSense develops wearable ECG patches and a cloud platform for continuous cardiac monitoring with automated arrhythmia alerts. |
| MindBridge | $900000 | Cardiff | Mental health; Peer support; Community health; Social prescribing | MindBridge builds a moderated social platform connecting people experiencing mental health challenges with peer mentors. |
| ClinTrialX | $5600000 | Oxford | Clinical trials; Patient recruitment; Research operations; AI | ClinTrialX develops AI software to match patients to open clinical trials and streamline trial site management workflows. |
| HealthNLP | $7800000 | London | NLP; Clinical documentation; EHR integration; Speech recognition | HealthNLP builds natural language processing tools for automating clinical note-taking and diagnostic coding in real time. |
Frequently Asked Questions
How much have Healthtech companies raised in total?
Healthtech companies in this dataset have collectively raised $85,200,000 in total.
Which Healthtech company has raised the most?
CardioSense has raised the most, securing $15,400,000 in funding.
What is the average funding (usd) for a Healthtech company in this dataset?
The average funding for a Healthtech company in this dataset is $5,680,000.